Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo

Abstract

Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China; Department of Cardiothoracic Surgery, Jinan People’s Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Imaging Department, Jinan People’s Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Anesthesiology, Shandong Provincial ENT Hospital Affiliated to Shandong University, Shandong Provincial ENT Hospital, Jinan, China Contributions: (I) Conception and design: XY Liu, YQ Zhao; (II) Administrative support: XY Liu; (III) Provision of study materials or patients: LF Wang, B Yin; (IV) Collection and assembly of data: T Wu, XM Song; (V) Data analysis and interpretation: M Shi, B Jiang, XG Sun; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Xiang-Yan Liu. Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan 250021, China. Email: [email protected].